Akira Yuasa

19PUBLICATIONS
12CO-AUTHORS
Molecular targetsPanel data analysisPharmaceutical delivery technologiesAnthropology of gender and sexualityNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 10, 2026
Cost-Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan.

Akira Yuasa, Kazumasa Kamei, Shota Saito

|Dec 08, 2025
Quantifying Disease Severity in Health Technology Assessment in Japan: A Retrospective Analysis Using Quality-Adjusted Life-Year Shortfalls.

Miwa Enami, Akira Yuasa, Shunya Ikeda

|Nov 04, 2025
Investigation of Differences Between Manufacturers and Public Analyses in Health Technology Assessment in Japan.

Yoko Hirano, Akira Yuasa, Karin Matsumoto

|Jun 27, 2025
Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan.

Norimitsu Saito, Kazumasa Kamei, Genevieve Gautier

|Feb 27, 2025
Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir Compared with Molnupiravir in Patients at High Risk for Progression to Severe COVID-19 in Japan.

Akira Yuasa, Hiroyuki Matsuda, Yosuke Fujii

|Sep 30, 2024
Impact of patient's financial burden of COVID-19 treatment on antiviral prescription rates and clinical and economic outcomes.

Mitsuhiro Nagano, Sachiko Hyokai, Kanae Togo

Pageof 4